Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2015
|
| In: |
Clinical lung cancer
Year: 2015, Jahrgang: 16, Heft: 5, Pages: 348-357 |
| ISSN: | 1938-0690 |
| DOI: | 10.1016/j.cllc.2015.01.004 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.cllc.2015.01.004
|
| Verfasserangaben: | Rodryg Ramlau, Michael Thomas, Silvia Novello, Ruth Plummer, Martin Reck, Tomomi Kaneko, Mike R. Lau, Jane Margetts, John Lunec, Joyce Nutt, Giorgio V. Scagliotti |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 155143959X | ||
| 003 | DE-627 | ||
| 005 | 20220813112752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170104s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cllc.2015.01.004 |2 doi | |
| 035 | |a (DE-627)155143959X | ||
| 035 | |a (DE-576)481439595 | ||
| 035 | |a (DE-599)BSZ481439595 | ||
| 035 | |a (OCoLC)1340949026 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ramlau, Rodryg |e VerfasserIn |0 (DE-588)1122679130 |0 (DE-627)876007353 |0 (DE-576)481439587 |4 aut | |
| 245 | 1 | 0 | |a Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker |c Rodryg Ramlau, Michael Thomas, Silvia Novello, Ruth Plummer, Martin Reck, Tomomi Kaneko, Mike R. Lau, Jane Margetts, John Lunec, Joyce Nutt, Giorgio V. Scagliotti |
| 264 | 1 | |c September 2015 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.01.2017 | ||
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical lung cancer |d Dallas, Tex. : Cancer Information Group, 1999 |g 16(2015), 5, Seite 348-357 |h Online-Ressource |w (DE-627)49143846X |w (DE-600)2193644-4 |w (DE-576)358410746 |x 1938-0690 |7 nnas |a Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker |
| 773 | 1 | 8 | |g volume:16 |g year:2015 |g number:5 |g pages:348-357 |g extent:10 |a Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cllc.2015.01.004 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170104 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 2 | ||
| 999 | |a KXP-PPN155143959X |e 2949772498 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker","title_sort":"Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarker"}],"note":["Gesehen am 04.01.2017"],"language":["eng"],"recId":"155143959X","relHost":[{"part":{"extent":"10","pages":"348-357","year":"2015","text":"16(2015), 5, Seite 348-357","issue":"5","volume":"16"},"titleAlt":[{"title":"Lung cancer"}],"disp":"Phase I study of lapatinib and pemetrexed in the second-line treatment of advanced or metastatic non-small-cell lung cancer with assessment of circulating cell free thymidylate synthase RNA as a potential biomarkerClinical lung cancer","title":[{"title":"Clinical lung cancer","title_sort":"Clinical lung cancer"}],"note":["Gesehen am 04.02.20"],"language":["eng"],"recId":"49143846X","pubHistory":["1.1999/2000 -"],"origin":[{"dateIssuedDisp":"1999-","publisher":"Cancer Information Group","dateIssuedKey":"1999","publisherPlace":"Dallas, Tex."}],"id":{"issn":["1938-0690"],"eki":["49143846X"],"zdb":["2193644-4"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"person":[{"family":"Ramlau","display":"Ramlau, Rodryg","given":"Rodryg","role":"aut"},{"given":"Michael","role":"aut","family":"Thomas","display":"Thomas, Michael"}],"name":{"displayForm":["Rodryg Ramlau, Michael Thomas, Silvia Novello, Ruth Plummer, Martin Reck, Tomomi Kaneko, Mike R. Lau, Jane Margetts, John Lunec, Joyce Nutt, Giorgio V. Scagliotti"]},"id":{"doi":["10.1016/j.cllc.2015.01.004"],"eki":["155143959X"]},"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"September 2015"}]} | ||
| SRT | |a RAMLAURODRPHASEISTUD2015 | ||